Lilly’s inventory has climbed within the triple digits over the previous 12 months. Eli Lilly’s (LLY 2.10%) shares have soared over the previous 12 months as the corporate grew its presence in what may grow to be a $100 billion drug market. The corporate sells two medication prescribed for weight reduction — Mounjaro and Zepbound…
